Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Motor phenotype classification in moderate to advanced PD in BioFIND study.

Luo L, Andrews H, Alcalay RN, Poyraz FC, Boehme AK, Goldman JG, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Sutherland M, Kopil C, Naito A, Kang UJ.

Parkinsonism Relat Disord. 2019 Jun 23. pii: S1353-8020(19)30280-9. doi: 10.1016/j.parkreldis.2019.06.017. [Epub ahead of print]

PMID:
31255537
2.

Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial.

Boxer AL, Qureshi I, Ahlijanian M, Grundman M, Golbe LI, Litvan I, Honig LS, Tuite P, McFarland NR, O'Suilleabhain P, Xie T, Tirucherai GS, Bechtold C, Bordelon Y, Geldmacher DS, Grossman M, Isaacson S, Zesiewicz T, Olsson T, Muralidharan KK, Graham DL, O'Gorman J, Haeberlein SB, Dam T.

Lancet Neurol. 2019 Jun;18(6):549-558. doi: 10.1016/S1474-4422(19)30139-5.

PMID:
31122495
3.

McLeod syndrome: Five new pedigrees with novel mutations.

Weaver J, Sarva H, Barone D, Bobker S, Bushara K, Hiller A, Ishii M, Jankovic J, Lakhani S, Niotis K, Scharre DW, Tuite P, Stutz A, Westhoff CM, Walker RH.

Parkinsonism Relat Disord. 2019 Jul;64:293-299. doi: 10.1016/j.parkreldis.2019.04.022. Epub 2019 May 2.

PMID:
31103486
4.

Somatosensory Training Improves Proprioception and Untrained Motor Function in Parkinson's Disease.

Elangovan N, Tuite PJ, Konczak J.

Front Neurol. 2018 Dec 10;9:1053. doi: 10.3389/fneur.2018.01053. eCollection 2018.

5.

Effects of yoga on oxidative stress, motor function, and non-motor symptoms in Parkinson's disease: a pilot randomized controlled trial.

Cheung C, Bhimani R, Wyman JF, Konczak J, Zhang L, Mishra U, Terluk M, Kartha RV, Tuite P.

Pilot Feasibility Stud. 2018 Oct 23;4:162. doi: 10.1186/s40814-018-0355-8. eCollection 2018.

6.

A Clinical Nurse Specialist-Led Initiative to Reduce Deficits in Tube Feeding Administration for the Surgical and Trauma Populations.

Bielewicz BJ, George E, Gunn S, Oroukin M, Ren D, Beach M, Tuite P.

Clin Nurse Spec. 2018 Nov/Dec;32(6):299-306. doi: 10.1097/NUR.0000000000000405.

PMID:
30299332
7.

Corrigendum: Multi-modal Brain MRI in Subjects with PD and iRBD.

Mangia S, Svatkova A, Mascali D, Nissi MJ, Burton PC, Bednarik P, Auerbach EJ, Giove F, Eberly LE, Howell MJ, Nestrasil I, Tuite PJ, Michaeli S.

Front Neurosci. 2018 Jun 26;12:446. doi: 10.3389/fnins.2018.00446. eCollection 2018.

8.

White matter measures correlate with essential tremor severity-A pilot diffusion tensor imaging study.

Nestrasil I, Svatkova A, Rudser KD, Chityala R, Wakumoto A, Mueller BA, Bednařík P, Tuite P, Wu X, Bushara K.

Brain Behav. 2018 Aug;8(8):e01039. doi: 10.1002/brb3.1039. Epub 2018 Jul 2.

9.

The effects of anodal tDCS over the supplementary motor area on gait initiation in Parkinson's disease with freezing of gait: a pilot study.

Lu C, Amundsen Huffmaster SL, Tuite PJ, MacKinnon CD.

J Neurol. 2018 Sep;265(9):2023-2032. doi: 10.1007/s00415-018-8953-1. Epub 2018 Jun 28.

PMID:
29956025
10.

Multi-modal Brain MRI in Subjects with PD and iRBD.

Mangia S, Svatkova A, Mascali D, Nissi MJ, Burton PC, Bednarik P, Auerbach EJ, Giove F, Eberly LE, Howell MJ, Nestrasil I, Tuite PJ, Michaeli S.

Front Neurosci. 2017 Dec 19;11:709. doi: 10.3389/fnins.2017.00709. eCollection 2017. Erratum in: Front Neurosci. 2018 Jun 26;12:446.

11.

Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.

Goldman JG, Andrews H, Amara A, Naito A, Alcalay RN, Shaw LM, Taylor P, Xie T, Tuite P, Henchcliffe C, Hogarth P, Frank S, Saint-Hilaire MH, Frasier M, Arnedo V, Reimer AN, Sutherland M, Swanson-Fischer C, Gwinn K; Fox Investigation of New Biomarker Discovery, Kang UJ.

Mov Disord. 2018 Feb;33(2):282-288. doi: 10.1002/mds.27232. Epub 2017 Dec 4.

12.

Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress.

Coles LD, Tuite PJ, Öz G, Mishra UR, Kartha RV, Sullivan KM, Cloyd JC, Terpstra M.

J Clin Pharmacol. 2018 Feb;58(2):158-167. doi: 10.1002/jcph.1008. Epub 2017 Sep 22.

13.

Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson's Disease (PD).

Tuite P.

Brain Sci. 2017 Jun 16;7(6). pii: E68. doi: 10.3390/brainsci7060068. Review.

14.

Effect of Cue Timing and Modality on Gait Initiation in Parkinson Disease With Freezing of Gait.

Lu C, Amundsen Huffmaster SL, Tuite PJ, Vachon JM, MacKinnon CD.

Arch Phys Med Rehabil. 2017 Jul;98(7):1291-1299.e1. doi: 10.1016/j.apmr.2017.01.009. Epub 2017 Feb 4.

15.

Improving Effectiveness and Satisfaction of an Electronic Charting System in Taiwan.

Hsieh HY, Henker R, Ren D, Chien WY, Chang JP, Chen L, Tuite PK.

Clin Nurse Spec. 2016 Nov/Dec;30(6):E1-E6.

PMID:
27753675
16.

Implementation of a Nurse-Led Family Meeting in a Neuroscience Intensive Care Unit.

Wu H, Ren D, Zinsmeister GR, Zewe GE, Tuite PK.

Dimens Crit Care Nurs. 2016 Sep-Oct;35(5):268-76. doi: 10.1097/DCC.0000000000000199.

PMID:
27487752
17.

Airway Management: A Structured Curriculum for Critical Care Transport Providers.

Kuszajewski ML, O'Donnell JM, Phrampus PE, Robey WC 3rd, Tuite PK.

Air Med J. 2016 May-Jun;35(3):138-42. doi: 10.1016/j.amj.2015.12.013. Epub 2016 Apr 16.

PMID:
27255875
18.

The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.

Kang UJ, Goldman JG, Alcalay RN, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Rudolph A, Casaceli C, Andrews H, Gwinn K, Sutherland M, Kopil C, Vincent L, Frasier M.

Mov Disord. 2016 Jun;31(6):924-32. doi: 10.1002/mds.26613. Epub 2016 Apr 26.

19.

Enhancing Nurses' Pain Assessment to Improve Patient Satisfaction.

Schroeder DL, Hoffman LA, Fioravanti M, Medley DP, Zullo TG, Tuite PK.

Orthop Nurs. 2016 Mar-Apr;35(2):108-17; quiz 118-9. doi: 10.1097/NOR.0000000000000226.

PMID:
27028687
20.

Increasing the Cultural Competence Levels of Undergraduate Nursing Students.

Govere L, Fioravanti MA, Tuite PK.

J Nurs Educ. 2016 Mar;55(3):155-9. doi: 10.3928/01484834-20160216-06.

PMID:
26926216
21.

Ready, S.E.T., go Improving patient-nurse communication.

Annonio D, Hoffman LA, Zedreck J, Robertson LB, Tuite PK.

Nurs Manage. 2016 Mar;47(3):40-9. doi: 10.1097/01.NUMA.0000480760.76675.8f. No abstract available.

PMID:
26914385
22.

Evaluation of a Surgical Site Discharge Teaching Tool Using Pictures and a Mirror.

Foertsch LY, Hoffmann RL, Ren D, Stolar J, Tuite PK.

Clin Nurse Spec. 2016 Mar-Apr;30(2):101-5. doi: 10.1097/NUR.0000000000000186.

PMID:
26848900
23.

Magnetic resonance imaging as a potential biomarker for Parkinson's disease.

Tuite P.

Transl Res. 2016 Sep;175:4-16. doi: 10.1016/j.trsl.2015.12.006. Epub 2015 Dec 17. Review.

PMID:
26763585
24.

Simulation education: early identification of patient physiologic deterioration by acute care nurses.

Ozekcin LR, Tuite P, Willner K, Hravnak M.

Clin Nurse Spec. 2015 May-Jun;29(3):166-73. doi: 10.1097/NUR.0000000000000123.

PMID:
25856034
25.

Effects of a video guided T'ai Chi group intervention on center of balance and falls efficacy: a pilot study.

Katrancha ED, Hoffman LA, Zullo TG, Tuite PK, Garand L.

Geriatr Nurs. 2015 Jan-Feb;36(1):9-14. doi: 10.1016/j.gerinurse.2014.08.015.

26.

Development and implementation of an educational support process for electronic nursing admission assessment documentation.

Evatt M, Ren D, Tuite P, Reynolds C, Hravnak M.

Medsurg Nurs. 2014 Mar-Apr;23(2):89-95, 100.

PMID:
24933785
27.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.

JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.

PMID:
24664227
28.

Magnetic Resonance Imaging (MRI) in Parkinson's Disease.

Tuite PJ, Mangia S, Michaeli S.

J Alzheimers Dis Parkinsonism. 2013 Mar 25;Suppl 1:001.

29.

N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.

Holmay MJ, Terpstra M, Coles LD, Mishra U, Ahlskog M, Öz G, Cloyd JC, Tuite PJ.

Clin Neuropharmacol. 2013 Jul-Aug;36(4):103-6. doi: 10.1097/WNF.0b013e31829ae713.

30.

Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification.

Hsu SC, Sears RL, Lemos RR, Quintáns B, Huang A, Spiteri E, Nevarez L, Mamah C, Zatz M, Pierce KD, Fullerton JM, Adair JC, Berner JE, Bower M, Brodaty H, Carmona O, Dobricić V, Fogel BL, García-Estevez D, Goldman J, Goudreau JL, Hopfer S, Janković M, Jaumà S, Jen JC, Kirdlarp S, Klepper J, Kostić V, Lang AE, Linglart A, Maisenbacher MK, Manyam BV, Mazzoni P, Miedzybrodzka Z, Mitarnun W, Mitchell PB, Mueller J, Novaković I, Paucar M, Paulson H, Simpson SA, Svenningsson P, Tuite P, Vitek J, Wetchaphanphesat S, Williams C, Yang M, Schofield PR, de Oliveira JR, Sobrido MJ, Geschwind DH, Coppola G.

Neurogenetics. 2013 Feb;14(1):11-22. doi: 10.1007/s10048-012-0349-2. Epub 2013 Jan 20.

31.

Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS.

Emir UE, Tuite PJ, Öz G.

PLoS One. 2012;7(1):e30918. doi: 10.1371/journal.pone.0030918. Epub 2012 Jan 25.

32.

Magnetization transfer and adiabatic R 1ρ MRI in the brainstem of Parkinson's disease.

Tuite PJ, Mangia S, Tyan AE, Lee MK, Garwood M, Michaeli S.

Parkinsonism Relat Disord. 2012 Jun;18(5):623-5. doi: 10.1016/j.parkreldis.2012.01.003. Epub 2012 Jan 20.

33.

Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours.

Friedman JH, Agarwal P, Alcalay R, Black KJ, Chou KL, Cote L, Dayalu P, Frank S, Hartlein J, Hauser RA, Lang AE, Marsh L, Marshall F, Moskowitz C, Ravina B, Riley D, Sanchez-Ramos J, Simon DK, Simuni T, Sutton J, Tuite P, Weintraub D, Zesiewicz T.

Int J Neurosci. 2011 Aug;121(8):472-6. doi: 10.3109/00207454.2011.578779. Epub 2011 Jun 10.

PMID:
21663381
34.

Novel mutations in siblings with later-onset PLA2G6-associated neurodegeneration (PLAN).

Bower MA, Bushara K, Dempsey MA, Das S, Tuite PJ.

Mov Disord. 2011 Aug 1;26(9):1768-9. doi: 10.1002/mds.23617. Epub 2011 Apr 25. No abstract available.

PMID:
21520282
35.

Impulsive behavior and associated clinical variables in Parkinson's disease.

Abosch A, Gupte A, Eberly LE, Tuite PJ, Nance M, Grant JE.

Psychosomatics. 2011 Jan-Feb;52(1):41-7. doi: 10.1016/j.psym.2010.11.013.

36.

Inferior olive response to passive tactile and visual stimulation with variable interstimulus intervals.

Wu X, Nestrasil I, Ashe J, Tuite P, Bushara K.

Cerebellum. 2010 Dec;9(4):598-602. doi: 10.1007/s12311-010-0203-8.

PMID:
20730634
37.

The effect of dopamine replacement therapy on haptic sensitivity in Parkinson's disease.

Li KY, Pickett K, Nestrasil I, Tuite P, Konczak J.

J Neurol. 2010 Dec;257(12):1992-8. doi: 10.1007/s00415-010-5646-9. Epub 2010 Jul 14.

PMID:
20628883
38.

The role of the clinical nurse specialist in facilitating evidence-based practice within a university setting.

Tuite PK, George EL.

Crit Care Nurs Q. 2010 Apr-Jun;33(2):117-25. doi: 10.1097/CNQ.0b013e3181d9138c.

PMID:
20234200
39.

T1rho and T2rho MRI in the evaluation of Parkinson's disease.

Nestrasil I, Michaeli S, Liimatainen T, Rydeen CE, Kotz CM, Nixon JP, Hanson T, Tuite PJ.

J Neurol. 2010 Jun;257(6):964-8. doi: 10.1007/s00415-009-5446-2. Epub 2010 Jan 8.

40.

Cardiac health: primary prevention of heart disease in women.

Turk MW, Tuite PK, Burke LE.

Nurs Clin North Am. 2009 Sep;44(3):315-25. doi: 10.1016/j.cnur.2009.06.001. Review.

41.

Proprioception and motor control in Parkinson's disease.

Konczak J, Corcos DM, Horak F, Poizner H, Shapiro M, Tuite P, Volkmann J, Maschke M.

J Mot Behav. 2009 Nov;41(6):543-52. doi: 10.3200/35-09-002. Review.

PMID:
19592360
42.

Haptic perception of object curvature in Parkinson's disease.

Konczak J, Li KY, Tuite PJ, Poizner H.

PLoS One. 2008 Jul 9;3(7):e2625. doi: 10.1371/journal.pone.0002625.

43.

ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand.

Weivoda S, Andersen JD, Skogen A, Schlievert PM, Fontana D, Schacker T, Tuite P, Dubinsky JM, Jemmerson R.

J Immunol Methods. 2008 Jul 20;336(1):22-9. doi: 10.1016/j.jim.2008.03.004. Epub 2008 Apr 4.

PMID:
18436231
44.

A process for instituting best practice in the intensive care unit.

George EL, Tuite P.

Indian J Crit Care Med. 2008 Apr;12(2):82-7. doi: 10.4103/0972-5229.42562.

45.

Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).

LeWitt PA, Guttman M, Tetrud JW, Tuite PJ, Mori A, Chaikin P, Sussman NM; 6002-US-005 Study Group.

Ann Neurol. 2008 Mar;63(3):295-302. doi: 10.1002/ana.21315.

PMID:
18306243
46.

Altered diffusion in the frontal lobe in Parkinson disease.

Karagulle Kendi AT, Lehericy S, Luciana M, Ugurbil K, Tuite P.

AJNR Am J Neuroradiol. 2008 Mar;29(3):501-5. doi: 10.3174/ajnr.A0850. Epub 2008 Jan 17.

47.

Gaze control and foot kinematics during stair climbing: characteristics leading to fall risk in progressive supranuclear palsy.

Di Fabio RP, Zampieri C, Tuite P.

Phys Ther. 2008 Feb;88(2):240-50. Epub 2007 Dec 11.

PMID:
18073265
48.

Interval timing and Parkinson's disease: heterogeneity in temporal performance.

Merchant H, Luciana M, Hooper C, Majestic S, Tuite P.

Exp Brain Res. 2008 Jan;184(2):233-48. Epub 2007 Sep 9.

PMID:
17828600
49.

The perception of passive motion in Parkinson's disease.

Konczak J, Krawczewski K, Tuite P, Maschke M.

J Neurol. 2007 May;254(5):655-63. Epub 2007 Apr 10.

PMID:
17420926
50.

Parkinsonism: a review-of-systems approach to diagnosis.

Tuite PJ, Krawczewski K.

Semin Neurol. 2007 Apr;27(2):113-22. Review.

PMID:
17390256

Supplemental Content

Support Center